1. Prevalence of mesothelin expression in peritoneal disease from colorectal and appendiceal cancers
   Dong H. Yoon et al, 2021, Journal of Surgical Oncology CrossRef
2. Characterization of Mesothelin Glycosylation in Pancreatic Cancer: Decreased Core Fucosylated Glycoforms in Pancreatic Cancer Patients’ Sera
   Adrià Duran et al, 2022, Biomedicines CrossRef
3. Clinical impacts of mesothelin expression in gastrointestinal carcinomas
   Takahiro Einama et al, 2016, World Journal of Gastrointestinal Pathophysiology CrossRef
4. Co-Expression of Mesothelin and CA125 Is Associated with the Poor Prognosis of Endometrial Serous Carcinoma and Mixed Carcinomas Including Serous Carcinoma
   Soichiro Kakimoto et al, 2020, Pathology & Oncology Research CrossRef
5. Significance of mesothelin and CA125 expression in endometrial carcinoma: a retrospective analysis
   Soichiro Kakimoto et al, 2021, Diagnostic Pathology CrossRef
6. The Role of Mesothelin as a Diagnostic and Therapeutic Target in Pancreatic Ductal Adenocarcinoma: A Comprehensive Review
   Federico Nichetti et al, 2018, Targeted Oncology CrossRef
7. INFLUENCE OF PROBIOTICS ON THE MESOTHELIN LEVEL IN WOMEN WITH ENDOMETRIOSIS ASSOCIATED WITH INFERTILITY IN COMPLEX PREPARATION FOR ASSISTED REPRODUCTIVE TECHNOLOGIES
   Oksana V. Bakun et al, 2023, Wiadomości Lekarskie CrossRef
8. Early administration of amatuximab, a chimeric high-affinity anti-mesothelin monoclonal antibody, suppresses liver metastasis of mesothelin-expressing pancreatic cancer cells and enhances gemcitabine sensitivity in a xenograft mouse model
   Yuki Fujii et al, 2021, Investigational New Drugs CrossRef
9. Mesothelin blockage by Amatuximab suppresses cell invasiveness, enhances gemcitabine sensitivity and regulates cancer cell stemness in mesothelin-positive pancreatic cancer cells
   Fumihiko Matsuzawa et al, 2021, BMC Cancer CrossRef